Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2022

View Archived Issues

S2K146 protects against SARS-CoV-2 infection in preclinical models

Exon-skipping antisense oligonucleotides show promise for treating cystic fibrosis

TRAF6 loss linked to development of myeloid malignancies

Discovery of novel mGlu4 receptor PAMs with antipsychotic-like properties

Zealand Pharma divulges LPAM-1 antagonists

Array BioPharma discloses new HER2 inhibitors

Cadila Healthcare synthesizes ENPP2 inhibitors

CGeneTech identifies new CDK inhibitors

Chinese investigators describe AGTR2 antagonists

Repurposed drug promoting systemic arginine catabolism improves energy homeostasis in obese mice

Synergistic antitumor activity of rencofilstat + anti-PD-1 in mice with fatty livers and HCC

IL-2Rbeta agonist MDNA-11 shows promising results in preclinical cancer models

Somatic tissue engineering gives insights into ovarian cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...